Back to search

Article

YAP/TAZ reverse progestin resistance through PI3K-Akt pathway in endometrial carcinoma

2022-08-09

Abstract excerpt

<title>Abstract</title><p><bold>Background:</bold>Progestin resistance is a problem for patients with endometrial carcinoma (EC) who require conservative treatment with progestin, and its underlying mechanisms remain unclear. YAP and TAZ (YAP/TAZ), downstream transcription coactivators of Hippo pathway, are highly expressed and induce aggressive phenotypes of EC. However, the role of YAP/TAZ in progestin resistanc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
70aef793-099c-54b6-9d12-884c26b9232f
DOI
10.21203/rs.3.rs-1922836/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
YAP/TAZ reverse progestin resistance through PI3K-Akt pathway in endometrial carcinomaDOI 10.21203/rs.3.rs-1922836/v1
Brusatol Sensitizes Endometrial Hyperplasia and Cancer to Progestin by Suppressing Nrf2-Tet1-AKR1C1-Mediated Progestin MetabolismSemantic proximity
Screening and identification of MSX1 for predicting progestin resistance in endometrial cancerSemantic proximity
Study of the Characterization of Side Population Cells in Endometrial Cancer Cell Lines: Chemoresistance, Progestin Resistance, and RadioresistanceSemantic proximity
Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial CarcinogenesisSemantic proximity
Levonorgestre-lintrauterine system(LNG-IUS) plus Metformin compared with Megestrol Acetate (MA)plus Metformin as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well differentiated endometrial cancer:a single-center retrospective studySemantic proximity
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by regulating the MGLL-ROS/AKR1C1 pathwaySemantic proximity
Hsa-circ-0001860 promotes Smad7 to enhance MPA resistance in endometrial cancer via miR-520hSemantic proximity
The IVF-generated human embryonic microenvironment reverses progestin resistance in endometrial cancer cells by inducing cancer stem cell differentiationSemantic proximity
Metapristone (RU486-derivative) inhibits endometrial cancer cell progress through regulating miR-492/Klf5/Nrf1 axisSemantic proximity
YY1/ITGA3 pathway may affect trophoblastic cells migration and invasion abilitySemantic proximity
miR-24-3p Promotes Cell Proliferation, Migration, and Invasion of Human Cervical Cancer Cells through/via Targeting AMOTL2 and Attenuating the YAP/Hippo PathwaySemantic proximity
G protein-coupled estrogen receptor promotes human extravillous trophoblast invasion via YAP-Snail-mediated CYR61 expressionSemantic proximity
Select a neighboring publication to make it the new centre.